This HTML5 document contains 108 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1093/ANNONC/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37405065
rdf:type
wikibase:Item
schema:description
videnskabelig artikel наукова стаття, опублікована в березні 2009 wissenschaftlicher Artikel vědecký článek artigo científico vedecký článok مقالة علمية نشرت في 02 مارس 2009 vetenskaplig artikel article scientifique bilimsel makale articolo scientifico article científic wetenschappelijk artikel scientific article published on 02 March 2009 artículu científicu espublizáu en 2009 научни чланак
p:P577
wds:Q37405065-84EBB6F3-6F0E-432F-9358-B12B643294AA
wdt:P577
2009-03-02T00:00:00Z
p:P2860
wds:Q37405065-F18D507E-8601-43EB-902E-1F567A591055 wds:Q37405065-F267A892-64ED-4332-BA9E-1A6510924502 wds:Q37405065-F9B218C8-E754-415D-ADEC-CEEA58023BD2 wds:Q37405065-DC712434-7BF9-415A-A9B4-CDC6FEDB574D wds:Q37405065-D3500337-A30F-4BBC-8C0E-6C6EFE27291B wds:Q37405065-9BB38ECD-A69E-4E19-9995-30E48B5AC762 wds:Q37405065-9DF7E395-8556-4BF0-9693-B079DF63DD06 wds:Q37405065-9E72D753-10CE-4F45-BE1A-5AC35598A691 wds:Q37405065-7C502041-BF15-4EBA-B16F-E4B3936220B4 wds:Q37405065-8A50DF30-A7F3-43FF-B7C5-F3AF4AC64641 wds:Q37405065-613A86CE-94E9-4FC9-8638-FE01B8A518A8 wds:Q37405065-6F5349CF-C5A3-4575-9711-BA2B41612F8A wds:Q37405065-5CAEE895-CBFD-4760-8BAC-20F28B1F7EC3 wds:Q37405065-412BA081-4207-4856-B2BA-5264E5935A5E wds:Q37405065-41E675A6-382D-4E7F-9AEC-D91A11F03FF4 wds:Q37405065-4750DDAA-C31B-4036-A340-79098A210C5D wds:Q37405065-0A2B58BE-F356-4924-9B0E-D78C0E5FC8BF wds:Q37405065-1EE3C621-0312-401E-90CC-8C39C03DDAEF wds:Q37405065-2258924E-0327-4D6B-9A9A-64FA36AE8BF3 wds:Q37405065-32216DDD-9FF9-45C1-93C9-CA0A7D59E00C wds:Q37405065-02C6DF60-222F-4B63-BD6A-4B2CF73CA489 wds:Q37405065-04AAB1DE-75CA-4A6F-A28B-A7C82BF86AF6 wds:Q37405065-05DF1597-B939-4313-9B19-57865EEC6CDF wds:Q37405065-00AFD5F4-939A-457B-8112-BBFBCF72DE21
wdt:P2860
wd:Q52035056 wd:Q29547513 wd:Q44659442 wd:Q35951294 wd:Q34463105 wd:Q46716134 wd:Q28262266 wd:Q45711262 wd:Q46494628 wd:Q35083639 wd:Q40462696 wd:Q25257496 wd:Q25257303 wd:Q28375904 wd:Q24813854 wd:Q36251476 wd:Q36805312 wd:Q27860904 wd:Q41640202 wd:Q29031162 wd:Q41699801 wd:Q36622959 wd:Q36709284 wd:Q38291062
p:P2093
wds:Q37405065-47A9A6CF-405D-4072-886D-4877F3BB3D74 wds:Q37405065-D7A7991F-D9A8-42FB-B65B-A4C9AF8BC7B2
wdt:P2093
L Y Dirix P A Canney
rdfs:label
Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer. Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer. Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer.
skos:prefLabel
Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer. Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer. Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer.
schema:name
Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer. Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer. Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer.
p:P50
wds:Q37405065-73D3A8D6-5349-4FF0-B7AE-43BDAF017607 wds:Q37405065-CEB49785-CDC5-4E67-979F-E1BC9322B994
wdt:P50
wd:Q79780278 wd:Q57316683
p:P1476
wds:Q37405065-E0EEFD3D-E0DC-40D2-A7B9-D592B38CC97C
wdt:P1476
Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer
p:P304
wds:Q37405065-0346DBD2-A9B6-4E3B-95D2-81C293025AC9
wdt:P304
615-620
p:P31
wds:Q37405065-4CAAD325-1F7E-4DA0-990E-EC26558692F6 wds:Q37405065-77bab84b-d854-40c2-beaf-b3a4bba6615b
wdt:P31
wd:Q7318358 wd:Q13442814
p:P921
wds:Q37405065-8CEC48DE-807C-4DC6-A5F0-1FB4519E438C
wdt:P921
wd:Q12859063
p:P698
wds:Q37405065-5245D005-4EA2-4A0B-8455-B8DCBCAA3A44
wdtn:P698
n11:19254941
wdt:P698
19254941
p:P1433
wds:Q37405065-4146741E-B36B-4777-9612-DC4D49F25017
wdt:P1433
wd:Q326122
p:P433
wds:Q37405065-D0602724-8EA9-4CF7-915C-730A46D964ED
p:P478
wds:Q37405065-6379428E-3A39-4222-AAB6-E749BCED8988
wdt:P433
4
wdt:P478
20
p:P356
wds:Q37405065-D626C206-276B-47C3-9916-150435325B2C
wdtn:P356
n9:MDN693
wdt:P356
10.1093/ANNONC/MDN693
p:P5875
wds:Q37405065-EC4634C6-7431-4283-92A4-D80DE00C646B
wdt:P5875
24171327